According to a new report Europe Eye Health Supplements Market, published by KBV research, the Europe Eye Health Supplements Market would witness market growth of 9.6% CAGR during the forecast period (2020-2026).
The Germany market dominated the Europe Cataract Market by Country in 2019, growing at a CAGR of 10.6 % during the forecast period. The UK market is experiencing a CAGR of 10.2% during (2020 - 2026). Additionally, The France market is poised to witness a CAGR of 12.7% during (2020 - 2026).
The Lutein and Zeaxanthin market dominated the Russia Eye Health Supplements Market by Ingredient Type in 2019, growing at a CAGR of 8 % during the forecast period. The Antioxidants market is estimated to grow at a CAGR of 8.8% during (2020 - 2026). The Flavonoids market is witnessing a CAGR of 11.2% during (2020 - 2026). Additionally, The Alpha-Lipoic Acid market would showcase highest CAGR of 11.7% during (2020 - 2026).
The Tablets market dominated the Italy Eye Health Supplements Market by Formulation in 2019, thereby, achieving a market value of $9.8 million by 2026. The Capsules market is estimated to grow at a CAGR of 9% during (2020 - 2026). Additionally, The Others market is expected to witness highest CAGR of 14.8% during (2020 - 2026).
Full Report: https://www.kbvresearch.com/europe-eye-health-supplements-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of The Nature’s Bounty Co. (The Carlyle Group L.P.), Pfizer, Inc., Alticor Inc. (Amway Corporation), Novartis AG, Kemin Industries, Inc., ZeaVision LLC (EyePromise), EyeScience Labs, LLC, Vitabiotics Ltd., Nutrivein and NutraChamps, Inc.
By Formulation
By Indication
By Ingredient Type
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
